109 related articles for article (PubMed ID: 34982495)
1. A Proton-Activatable DNA-Based Nanosystem Enables Co-Delivery of CRISPR/Cas9 and DNAzyme for Combined Gene Therapy.
Li F; Song N; Dong Y; Li S; Li L; Liu Y; Li Z; Yang D
Angew Chem Int Ed Engl; 2022 Feb; 61(9):e202116569. PubMed ID: 34982495
[TBL] [Abstract][Full Text] [Related]
2. Autonomous Feedback-Driven Engineered DNAzyme-Coated Trojan Horse-like Nanocapsules for On-Demand CRISPR/Cas9 Delivery.
Tang X; Chen Y; Wang B; Luo D; Wang J; He Y; Feng L; Xu Y; Xie S; Chen M; Chang K
ACS Nano; 2024 May; 18(21):13950-13965. PubMed ID: 38751197
[TBL] [Abstract][Full Text] [Related]
3. DNAzyme activated protein-scaffolded CRISPR-Cas9 nanoassembly for genome editing.
Zhu X; Lv MM; Liu JW; Yu RQ; Jiang JH
Chem Commun (Camb); 2019 Jun; 55(46):6511-6514. PubMed ID: 31099367
[TBL] [Abstract][Full Text] [Related]
4. A DNA Nanocomplex Containing Cascade DNAzymes and Promoter-Like Zn-Mn-Ferrite for Combined Gene/Chemo-dynamic Therapy.
Yao C; Qi H; Jia X; Xu Y; Tong Z; Gu Z; Yang D
Angew Chem Int Ed Engl; 2022 Feb; 61(6):e202113619. PubMed ID: 34866297
[TBL] [Abstract][Full Text] [Related]
5. Scaffold-mediated non-viral delivery platform for CRISPR/Cas9-based genome editing.
Chin JS; Chooi WH; Wang H; Ong W; Leong KW; Chew SY
Acta Biomater; 2019 May; 90():60-70. PubMed ID: 30978509
[TBL] [Abstract][Full Text] [Related]
6. Biomimetic Construction of Degradable DNAzyme-Loaded Nanocapsules for Self-Sufficient Gene Therapy of Pulmonary Metastatic Breast Cancer.
Jiang R; Li L; Li M
ACS Nano; 2023 Nov; 17(21):22129-22144. PubMed ID: 37925681
[TBL] [Abstract][Full Text] [Related]
7. Photoactivatable Engineering of CRISPR/Cas9-Inducible DNAzyme Probe for In Situ Imaging of Nuclear Zinc Ions.
Liu R; Jiang D; Yun Y; Feng Z; Zheng F; Xiang Y; Fan H; Zhang J
Angew Chem Int Ed Engl; 2024 Mar; 63(10):e202315536. PubMed ID: 38253802
[TBL] [Abstract][Full Text] [Related]
8. Core-Shell Nanosystems for Self-Activated Drug-Gene Combinations against Triple-Negative Breast Cancer.
Liu P; Liu X; Cheng Y; Zhong S; Shi X; Wang S; Liu M; Ding J; Zhou W
ACS Appl Mater Interfaces; 2020 Dec; 12(48):53654-53664. PubMed ID: 33205940
[TBL] [Abstract][Full Text] [Related]
9. High-Fidelity CRISPR/Cas13a
Zhou T; Huang M; Lin J; Huang R; Xing D
Anal Chem; 2021 Feb; 93(4):2038-2044. PubMed ID: 33411517
[TBL] [Abstract][Full Text] [Related]
10. A Synergistic DNA-polydopamine-MnO
Zhao H; Zhang Z; Zuo D; Li L; Li F; Yang D
Nano Lett; 2021 Jun; 21(12):5377-5385. PubMed ID: 34100622
[TBL] [Abstract][Full Text] [Related]
11. Nonviolent Self-Catabolic DNAzyme Nanosponges for Smart Anticancer Drug Delivery.
Wang J; Wang H; Wang H; He S; Li R; Deng Z; Liu X; Wang F
ACS Nano; 2019 May; 13(5):5852-5863. PubMed ID: 31042356
[TBL] [Abstract][Full Text] [Related]
12. A Self-Assembled Platform Based on Branched DNA for sgRNA/Cas9/Antisense Delivery.
Liu J; Wu T; Lu X; Wu X; Liu S; Zhao S; Xu X; Ding B
J Am Chem Soc; 2019 Dec; 141(48):19032-19037. PubMed ID: 31729871
[TBL] [Abstract][Full Text] [Related]
13. Versatile Catalytic Deoxyribozyme Vehicles for Multimodal Imaging-Guided Efficient Gene Regulation and Photothermal Therapy.
Feng J; Xu Z; Liu F; Zhao Y; Yu W; Pan M; Wang F; Liu X
ACS Nano; 2018 Dec; 12(12):12888-12901. PubMed ID: 30540434
[TBL] [Abstract][Full Text] [Related]
14. Orthogonal Chemical Activation of Enzyme-Inducible CRISPR/Cas9 for Cell-Selective Genome Editing.
Cai W; Liu J; Chen X; Mao L; Wang M
J Am Chem Soc; 2022 Dec; 144(48):22272-22280. PubMed ID: 36367552
[TBL] [Abstract][Full Text] [Related]
15. Near-infrared optogenetic engineering of photothermal nanoCRISPR for programmable genome editing.
Chen X; Chen Y; Xin H; Wan T; Ping Y
Proc Natl Acad Sci U S A; 2020 Feb; 117(5):2395-2405. PubMed ID: 31941712
[TBL] [Abstract][Full Text] [Related]
16. A Smart Theranostic Nanocapsule for Spatiotemporally Programmable Photo-Gene Therapy.
Gong X; Li R; Wang J; Wei J; Ma K; Liu X; Wang F
Angew Chem Int Ed Engl; 2020 Nov; 59(48):21648-21655. PubMed ID: 32767817
[TBL] [Abstract][Full Text] [Related]
17. DNAzyme-Loaded Metal-Organic Frameworks (MOFs) for Self-Sufficient Gene Therapy.
Wang H; Chen Y; Wang H; Liu X; Zhou X; Wang F
Angew Chem Int Ed Engl; 2019 May; 58(22):7380-7384. PubMed ID: 30916460
[TBL] [Abstract][Full Text] [Related]
18. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy.
Ghaemi A; Bagheri E; Abnous K; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2021 Feb; 267():118969. PubMed ID: 33385410
[TBL] [Abstract][Full Text] [Related]
20. Strategies for nonviral nanoparticle-based delivery of CRISPR/Cas9 therapeutics.
Chen F; Alphonse M; Liu Q
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 May; 12(3):e1609. PubMed ID: 31797562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
